Skip to main content
Erschienen in: Abdominal Radiology 12/2017

16.06.2017 | Invited article

Collision and composite tumors; radiologic and pathologic correlation

verfasst von: Calvin T. Sung, Anup Shetty, Christine O. Menias, Roozbeh Houshyar, Shreya Chatterjee, Thomas K. Lee, Paul Tung, Mohammed Helmy, Chandana Lall

Erschienen in: Abdominal Radiology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

The terms composite and collision tumors have been used interchangeably throughout radiological literature. Both composite and collision tumors involve two morphologically and immunohistochemically distinct neoplasms coexisting within a single organ. However, collision tumors lack the histological cellular intermingling seen in composite tumors. Composite tumors often arise from a common driver mutation that induces a divergent histology from a common neoplastic source while collision tumors may arise from coincidental neoplastic change. The purpose of this review is to provide an overview of abdominal composite and collision tumors by discussing hallmark radiographic and pathological presentations of rare hepatic, renal, and adrenal case studies. A better understanding of the presentation of each lesion is imperative for proper recognition, diagnosis, and management of these unique tumor presentations.
Literatur
3.
Zurück zum Zitat Michalinos A, Constantinidou A, Kontos M (2015) Gastric collision tumors: an insight into their origin and clinical significance. Gastroenterol Res Pract 2015:314158CrossRefPubMedPubMedCentral Michalinos A, Constantinidou A, Kontos M (2015) Gastric collision tumors: an insight into their origin and clinical significance. Gastroenterol Res Pract 2015:314158CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Aggarwal N, et al. (2012) Tumor-to-tumor metastasis: case report of a pulmonary adenocarcinoma metastatic to a clear cell renal cell carcinoma. Pathol Res Pract 208(1):50–52CrossRefPubMed Aggarwal N, et al. (2012) Tumor-to-tumor metastasis: case report of a pulmonary adenocarcinoma metastatic to a clear cell renal cell carcinoma. Pathol Res Pract 208(1):50–52CrossRefPubMed
5.
Zurück zum Zitat Anani W, et al. (2014) A series of collision tumors in the genitourinary tract with a review of the literature. Pathol Res Pract 210(4):217–223CrossRefPubMed Anani W, et al. (2014) A series of collision tumors in the genitourinary tract with a review of the literature. Pathol Res Pract 210(4):217–223CrossRefPubMed
7.
Zurück zum Zitat Brandwein-Gensler M, Urken M, Wang B (2004) Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma. Head Neck 26(7):637–641CrossRefPubMed Brandwein-Gensler M, Urken M, Wang B (2004) Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma. Head Neck 26(7):637–641CrossRefPubMed
8.
Zurück zum Zitat Chin S, Kim Z (2014) Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature. Int J Clin Exp Pathol 7(11):8290–8294PubMedPubMedCentral Chin S, Kim Z (2014) Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature. Int J Clin Exp Pathol 7(11):8290–8294PubMedPubMedCentral
9.
Zurück zum Zitat Shetty AS, et al. (2014) Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma. Abdom Imaging 39(2):310–322CrossRefPubMed Shetty AS, et al. (2014) Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma. Abdom Imaging 39(2):310–322CrossRefPubMed
10.
Zurück zum Zitat Jarnagin WR, et al. (2002) Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 94(7):2040–2046CrossRefPubMed Jarnagin WR, et al. (2002) Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 94(7):2040–2046CrossRefPubMed
11.
Zurück zum Zitat Lee SD, et al. (2014) Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery. Hepatobiliary Pancreat Dis Int 13(6):594–601CrossRefPubMed Lee SD, et al. (2014) Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery. Hepatobiliary Pancreat Dis Int 13(6):594–601CrossRefPubMed
12.
Zurück zum Zitat Lee JH, et al. (2011) Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol 45(1):69–75PubMed Lee JH, et al. (2011) Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol 45(1):69–75PubMed
13.
Zurück zum Zitat Yin X, et al. (2012) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol 19(9):2869–2876CrossRefPubMed Yin X, et al. (2012) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol 19(9):2869–2876CrossRefPubMed
14.
Zurück zum Zitat Panjala C, et al. (2010) The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant 10(5):1263–1267CrossRefPubMed Panjala C, et al. (2010) The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant 10(5):1263–1267CrossRefPubMed
15.
Zurück zum Zitat Liu CL, et al. (2003) Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 138(1):86–90CrossRefPubMed Liu CL, et al. (2003) Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 138(1):86–90CrossRefPubMed
16.
Zurück zum Zitat Wang J, Wang F, Kessinger A (2010) Outcome of combined hepatocellular and cholangiocarcinoma of the liver. J Oncol 2010:7 Wang J, Wang F, Kessinger A (2010) Outcome of combined hepatocellular and cholangiocarcinoma of the liver. J Oncol 2010:7
17.
Zurück zum Zitat Chi M, et al. (2012) Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review. Gastrointest Cancer Res 5(6):199–202PubMedPubMedCentral Chi M, et al. (2012) Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review. Gastrointest Cancer Res 5(6):199–202PubMedPubMedCentral
18.
Zurück zum Zitat Sapisochin G, et al. (2011) Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl 17(8):934–942CrossRefPubMed Sapisochin G, et al. (2011) Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl 17(8):934–942CrossRefPubMed
19.
Zurück zum Zitat Theise N, et al. (2010) Combined hepatocellular-cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) Who classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer, pp 225–227 Theise N, et al. (2010) Combined hepatocellular-cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) Who classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer, pp 225–227
20.
Zurück zum Zitat Purysko AS, et al. (2012) LI-RADS: a case-based review of the new categorization of liver findings in patients with end-stage liver disease. Radiographics 32(7):1977–1995CrossRefPubMed Purysko AS, et al. (2012) LI-RADS: a case-based review of the new categorization of liver findings in patients with end-stage liver disease. Radiographics 32(7):1977–1995CrossRefPubMed
22.
23.
Zurück zum Zitat Akiba J, et al. (2013) Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol 37(4):496–505CrossRefPubMed Akiba J, et al. (2013) Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol 37(4):496–505CrossRefPubMed
24.
Zurück zum Zitat Kassahun WT, Hauss J (2008) Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 62(8):1271–1278CrossRefPubMed Kassahun WT, Hauss J (2008) Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 62(8):1271–1278CrossRefPubMed
25.
Zurück zum Zitat Yang JD, et al. (2011) Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 9(7):617–623CrossRefPubMed Yang JD, et al. (2011) Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 9(7):617–623CrossRefPubMed
26.
Zurück zum Zitat Sempoux C, et al. (2011) Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 31(1):49–60CrossRefPubMed Sempoux C, et al. (2011) Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 31(1):49–60CrossRefPubMed
27.
28.
Zurück zum Zitat Xu J, et al. (2016) Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases. Zhonghua Bing Li Xue Za Zhi 45(3):175–179PubMed Xu J, et al. (2016) Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases. Zhonghua Bing Li Xue Za Zhi 45(3):175–179PubMed
29.
Zurück zum Zitat Zhang F, et al. (2008) Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 52(2):224–232CrossRefPubMed Zhang F, et al. (2008) Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 52(2):224–232CrossRefPubMed
30.
31.
Zurück zum Zitat Allaire GS, et al. (1988) Bile duct adenoma. a study of 152 cases. Am J Surg Pathol 12(9):708–715CrossRefPubMed Allaire GS, et al. (1988) Bile duct adenoma. a study of 152 cases. Am J Surg Pathol 12(9):708–715CrossRefPubMed
33.
Zurück zum Zitat Aoki K, et al. (1993) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 18(5):1090–1095CrossRefPubMed Aoki K, et al. (1993) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 18(5):1090–1095CrossRefPubMed
34.
Zurück zum Zitat Chen LD, et al. (2010) Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 20(3):743–753CrossRefPubMed Chen LD, et al. (2010) Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 20(3):743–753CrossRefPubMed
35.
Zurück zum Zitat Leoni S, et al. (2010) The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 105(3):599–609CrossRefPubMed Leoni S, et al. (2010) The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 105(3):599–609CrossRefPubMed
36.
Zurück zum Zitat Sherman M (2010) The radiological diagnosis of hepatocellular carcinoma. In: Am J Gastroenterol. United States. p 610–612. Sherman M (2010) The radiological diagnosis of hepatocellular carcinoma. In: Am J Gastroenterol. United States. p 610–612.
37.
Zurück zum Zitat Ros PR, et al. (1986) Mesenchymal hamartoma of the liver: radiologic-pathologic correlation. Radiology 158(3):619–624CrossRefPubMed Ros PR, et al. (1986) Mesenchymal hamartoma of the liver: radiologic-pathologic correlation. Radiology 158(3):619–624CrossRefPubMed
38.
Zurück zum Zitat Kim KA, et al. (2006) Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation. AJR Am J Roentgenol 187(5):W481–W489CrossRefPubMed Kim KA, et al. (2006) Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation. AJR Am J Roentgenol 187(5):W481–W489CrossRefPubMed
39.
Zurück zum Zitat Lai FM, et al. (1996) Hepatic mesenchymal hamartoma: a case report and radiological findings. Singap Med J 37(2):226–228 Lai FM, et al. (1996) Hepatic mesenchymal hamartoma: a case report and radiological findings. Singap Med J 37(2):226–228
43.
Zurück zum Zitat Cornette J, et al. (2009) Mesenchymal hamartoma of the liver: a benign tumor with deceptive prognosis in the perinatal period. Case report and review of the literature. Fetal Diagn Ther 25(2):196–202CrossRefPubMed Cornette J, et al. (2009) Mesenchymal hamartoma of the liver: a benign tumor with deceptive prognosis in the perinatal period. Case report and review of the literature. Fetal Diagn Ther 25(2):196–202CrossRefPubMed
44.
Zurück zum Zitat Anil G, Fortier M, Low Y (1001) Cystic hepatic mesenchymal hamartoma: the role of radiology in diagnosis and perioperative management. Br J Radiol 2011(84):e91–e94 Anil G, Fortier M, Low Y (1001) Cystic hepatic mesenchymal hamartoma: the role of radiology in diagnosis and perioperative management. Br J Radiol 2011(84):e91–e94
45.
46.
Zurück zum Zitat Lall C, et al. (2015) Renal collision and composite tumors: imaging and pathophysiology. Urology 86(6):1159–1164CrossRefPubMed Lall C, et al. (2015) Renal collision and composite tumors: imaging and pathophysiology. Urology 86(6):1159–1164CrossRefPubMed
47.
Zurück zum Zitat Lopez-Beltran A, et al. (2006) 2004 WHO classification of the renal tumors of the adults. Eur Urol 49(5):798–805CrossRefPubMed Lopez-Beltran A, et al. (2006) 2004 WHO classification of the renal tumors of the adults. Eur Urol 49(5):798–805CrossRefPubMed
48.
Zurück zum Zitat Waldert M, et al. (2010) Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol 57(4):661–665CrossRefPubMed Waldert M, et al. (2010) Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol 57(4):661–665CrossRefPubMed
49.
Zurück zum Zitat Su D, Singer EA, Srinivasan R (2015) Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology. Curr Opin Oncol 27(3):217–223CrossRefPubMed Su D, Singer EA, Srinivasan R (2015) Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology. Curr Opin Oncol 27(3):217–223CrossRefPubMed
50.
Zurück zum Zitat Mucciardi G, et al. (2015) Transitional cell carcinoma of the renal pelvis with synchronous ipsilateral papillary renal cell carcinoma: case report and review. Urol Case Rep 3(4):93–95CrossRefPubMedPubMedCentral Mucciardi G, et al. (2015) Transitional cell carcinoma of the renal pelvis with synchronous ipsilateral papillary renal cell carcinoma: case report and review. Urol Case Rep 3(4):93–95CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Upton MP, et al. (2005) Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother 28(5):488–495CrossRefPubMed Upton MP, et al. (2005) Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother 28(5):488–495CrossRefPubMed
52.
Zurück zum Zitat Escudier B, et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356(2):125–134CrossRefPubMed Escudier B, et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356(2):125–134CrossRefPubMed
53.
Zurück zum Zitat Polascik TJ, Bostwick DG, Cairns P (2002) Molecular genetics and histopathologic features of adult distal nephron tumors. Urology 60(6):941–946CrossRefPubMed Polascik TJ, Bostwick DG, Cairns P (2002) Molecular genetics and histopathologic features of adult distal nephron tumors. Urology 60(6):941–946CrossRefPubMed
54.
Zurück zum Zitat Sukosd F, et al. (2003) Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 63(2):455–457PubMed Sukosd F, et al. (2003) Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 63(2):455–457PubMed
55.
Zurück zum Zitat Gurel S, et al. (2013) Subtypes of renal cell carcinoma: MRI and pathological features. Diagn Interv Radiol 19(4):304–311PubMed Gurel S, et al. (2013) Subtypes of renal cell carcinoma: MRI and pathological features. Diagn Interv Radiol 19(4):304–311PubMed
56.
Zurück zum Zitat Sun MR, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology 250(3):793–802CrossRefPubMed Sun MR, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology 250(3):793–802CrossRefPubMed
57.
Zurück zum Zitat Vargas HA, et al. (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology 264(3):779–788CrossRefPubMed Vargas HA, et al. (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology 264(3):779–788CrossRefPubMed
58.
Zurück zum Zitat Gordetsky J, Zarzour J (2016) Correlating preoperative imaging with histologic subtypes of renal cell carcinoma and common mimickers. Curr Urol Rep 17(7):52CrossRefPubMed Gordetsky J, Zarzour J (2016) Correlating preoperative imaging with histologic subtypes of renal cell carcinoma and common mimickers. Curr Urol Rep 17(7):52CrossRefPubMed
59.
60.
Zurück zum Zitat Davidson AJ, et al. (1993) Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 186(3):693–696CrossRefPubMed Davidson AJ, et al. (1993) Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 186(3):693–696CrossRefPubMed
61.
Zurück zum Zitat Rosenkrantz AB, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 195(6):W421–W427CrossRefPubMed Rosenkrantz AB, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 195(6):W421–W427CrossRefPubMed
62.
Zurück zum Zitat Perez-Ordonez B, et al. (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21(8):871–883CrossRefPubMed Perez-Ordonez B, et al. (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21(8):871–883CrossRefPubMed
63.
Zurück zum Zitat Harmon WJ, King BF, Lieber MM (1996) Renal oncocytoma: magnetic resonance imaging characteristics. J Urol 155(3):863–867CrossRefPubMed Harmon WJ, King BF, Lieber MM (1996) Renal oncocytoma: magnetic resonance imaging characteristics. J Urol 155(3):863–867CrossRefPubMed
64.
Zurück zum Zitat Rosenkrantz AB, et al. (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 195(5):W344–W351CrossRefPubMed Rosenkrantz AB, et al. (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 195(5):W344–W351CrossRefPubMed
65.
Zurück zum Zitat Taouli B, et al. (2009) Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251(2):398–407CrossRefPubMed Taouli B, et al. (2009) Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251(2):398–407CrossRefPubMed
66.
Zurück zum Zitat Mugiya S, et al. (2004) Ultrasonographic features of chromophobe cell renal carcinoma. Hinyokika Kiyo 50(12):865–868PubMed Mugiya S, et al. (2004) Ultrasonographic features of chromophobe cell renal carcinoma. Hinyokika Kiyo 50(12):865–868PubMed
67.
Zurück zum Zitat Kondo T, et al. (2004) Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies. Int J Urol 11(10):817–824CrossRefPubMed Kondo T, et al. (2004) Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies. Int J Urol 11(10):817–824CrossRefPubMed
68.
Zurück zum Zitat Shuch B, et al. (2012) Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist 17(1):46–54CrossRefPubMedPubMedCentral Shuch B, et al. (2012) Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist 17(1):46–54CrossRefPubMedPubMedCentral
69.
Zurück zum Zitat de Peralta-Venturina M, et al. (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25(3):275–284CrossRefPubMed de Peralta-Venturina M, et al. (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25(3):275–284CrossRefPubMed
70.
Zurück zum Zitat Cheville JC, et al. (2004) Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28(4):435–441CrossRefPubMed Cheville JC, et al. (2004) Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28(4):435–441CrossRefPubMed
71.
Zurück zum Zitat Shuch B, et al. (2009) Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology–is up-front resection indicated and if not, is it avoidable? J Urol 182(5):2164–2171CrossRefPubMedPubMedCentral Shuch B, et al. (2009) Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology–is up-front resection indicated and if not, is it avoidable? J Urol 182(5):2164–2171CrossRefPubMedPubMedCentral
72.
Zurück zum Zitat Schieda N, et al. (2015) Diagnosis of sarcomatoid renal cell carcinoma with CT: evaluation by qualitative imaging features and texture analysis. AJR Am J Roentgenol 204(5):1013–1023CrossRefPubMed Schieda N, et al. (2015) Diagnosis of sarcomatoid renal cell carcinoma with CT: evaluation by qualitative imaging features and texture analysis. AJR Am J Roentgenol 204(5):1013–1023CrossRefPubMed
73.
Zurück zum Zitat Sant GR, et al. (1984) Computed tomographic findings in renal angiomyolipoma: an histologic correlation. Urology 24(3):293–296CrossRefPubMed Sant GR, et al. (1984) Computed tomographic findings in renal angiomyolipoma: an histologic correlation. Urology 24(3):293–296CrossRefPubMed
74.
Zurück zum Zitat Kloos RT, et al. (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460–484PubMed Kloos RT, et al. (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460–484PubMed
75.
76.
Zurück zum Zitat Ctvrtlik F, et al. (2009) Differential diagnosis of incidentally detected adrenal masses revealed on routine abdominal CT. Eur J Radiol 69(2):243–252CrossRefPubMed Ctvrtlik F, et al. (2009) Differential diagnosis of incidentally detected adrenal masses revealed on routine abdominal CT. Eur J Radiol 69(2):243–252CrossRefPubMed
77.
Zurück zum Zitat Johnson PT, Horton KM, Fishman EK (2009) Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 29(5):1333–1351CrossRefPubMed Johnson PT, Horton KM, Fishman EK (2009) Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 29(5):1333–1351CrossRefPubMed
78.
Zurück zum Zitat Otal P, et al. (1999) Imaging features of uncommon adrenal masses with histopathologic correlation. Radiographics 19(3):569–581CrossRefPubMed Otal P, et al. (1999) Imaging features of uncommon adrenal masses with histopathologic correlation. Radiographics 19(3):569–581CrossRefPubMed
79.
Zurück zum Zitat Johnson PT, Horton KM, Fishman EK (2009) Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice. Radiographics 29(5):1319–1331CrossRefPubMed Johnson PT, Horton KM, Fishman EK (2009) Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice. Radiographics 29(5):1319–1331CrossRefPubMed
80.
Zurück zum Zitat Piotrowski Z, et al. (2015) Renal cell carcinoma and an incidental adrenal lesion: adrenal collision tumors. Urology 85(3):e17–e18CrossRefPubMed Piotrowski Z, et al. (2015) Renal cell carcinoma and an incidental adrenal lesion: adrenal collision tumors. Urology 85(3):e17–e18CrossRefPubMed
81.
Zurück zum Zitat Reznek RH, Armstrong P (1994) The adrenal gland. Clin Endocrinol 40(5):561–576CrossRef Reznek RH, Armstrong P (1994) The adrenal gland. Clin Endocrinol 40(5):561–576CrossRef
82.
Zurück zum Zitat Szolar DH, Kammerhuber F (1997) Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202(2):517–521CrossRefPubMed Szolar DH, Kammerhuber F (1997) Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202(2):517–521CrossRefPubMed
Metadaten
Titel
Collision and composite tumors; radiologic and pathologic correlation
verfasst von
Calvin T. Sung
Anup Shetty
Christine O. Menias
Roozbeh Houshyar
Shreya Chatterjee
Thomas K. Lee
Paul Tung
Mohammed Helmy
Chandana Lall
Publikationsdatum
16.06.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 12/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1200-x

Weitere Artikel der Ausgabe 12/2017

Abdominal Radiology 12/2017 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.